We’ve got preferences and so do you
Is it possible for a global CRO to improve – and even reshape – today’s drug development industry? We think so. We work with people like you to offer unique perspectives at every stage of development –...
View ArticleIND-Enabling programs for gene therapies
Gene therapies continue to hold promise as treatments for many diseases but there are numerous and unique challenges to developing them for submission as an Investigational New Drug (IND)/...
View ArticleEnhancing the Investigator Site Experience with Electronic Query Notification...
Investigator sites provide an essential connection between drug development sponsors and patients in clinical trials—and play a key role in producing high-quality data. To better support a site’s...
View ArticleAddressing Challenges with Ulcerative Colitis Clinical Study Recruitment
We understand the significant challenges sponsors face with patient recruitment in their ulcerative colitis (UC) clinical studies. While the prevalence of UC is relatively high (~0.2% in North America,...
View ArticleRare Disease Day 2022: Supporting patients, celebrating advancements
February 28 is Rare Disease Day, a day dear to the hearts of many at Labcorp. The day is observed to raise awareness and give support to the more than 300 million people worldwide living with rare...
View ArticleScience that never sleeps
When you have a global footprint spanning every time zone, there’s no such thing as working from “9 to 5.” You just have to know how to work the clock. That’s the idea behind our Follow the Sun...
View ArticleLong COVID Q&A: 4 things to know about COVID cognitive dysfunction
Long COVID is a colloquial term used to describe the lingering health symptoms some patients experience after contracting the COVID-19 virus. While the majority of people fully recover from the virus,...
View Article5 key takeaways from a Labcorp webinar: Current and emerging Parkinson’s...
Insights from our three guest speakers: Robert Martone, Associate Director, Neurology Biomarkers, Labcorp Biomarker Solution Center, Labcorp Drug Development Hiba Kazmi, PhD, Biomarker Scientist, IXICO...
View Article
